Kawasaki Disease

Area of Science:

• Pediatrics
• Cardiology
• Rheumatology

Background:

• Kawasaki disease is a critical pediatric vasculitis impacting coronary arteries.
• Delayed treatment elevates the risk of coronary artery aneurysms, a major cause of cardiac morbidity.
• Aneurysms can progress, leading to stenosis and myocardial infarction, even in adulthood.

Purpose of the Study:

• To highlight the critical importance of early intravenous immunoglobulin treatment for Kawasaki disease.
• To underscore the long-term cardiovascular sequelae of untreated or delayed-treated Kawasaki disease.
• To inform about the evolving nature of coronary artery aneurysms and their management.

Main Methods:

• Review of clinical data and outcomes in Kawasaki disease patients.
• Analysis of the impact of treatment timing on coronary artery aneurysm formation.
• Longitudinal observation of aneurysm evolution and associated cardiovascular events.

Main Results:

• Intravenous immunoglobulin within 10 days of fever onset reduces aneurysm risk fivefold.
• Coronary artery aneurysms peak in size by 6 weeks but can progress over years.
• Kawasaki disease is an emerging cause of acute coronary syndrome in young adults.

Conclusions:

• Prompt diagnosis and treatment of Kawasaki disease are vital to prevent severe coronary artery damage.
• Long-term cardiovascular surveillance is necessary for patients with Kawasaki disease, especially those with aneurysms.
• Management strategies for Kawasaki disease-induced coronary artery disease include surgical and interventional approaches.